Latanoprost for Glaucoma
What You Need to Know Before You Apply
What is the purpose of this trial?
Persons who do not have glaucoma will have pictures taken of the optic nerve with a standard camera before and 2 weeks after starting to take a daily glaucoma eye drop to lower eye pressure. These data will be used to compare to the same procedure performed with glaucoma patients to study how glaucoma injures the eye.
Who Is on the Research Team?
Harry Quigley, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults over 30 who do not have glaucoma, have healthy eye exams and scans, and no signs of optic nerve damage. Both men and women from any ethnic background can join if their eyes are healthy.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Latanoprost
Trial Overview
The study tests the effect of daily Latanoprost (an eye drop that lowers eye pressure) on the optic nerve in people without glaucoma. Pictures of the optic nerve are taken before starting drops and after two weeks to see changes.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
The participants will take an approved glaucoma eye drop, latanoprost, for less than one month, with pictures of the eyes at baseline and while taking the drop.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Eye Institute (NEI)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.